Next-generation drug-eluting stent approved by Health CanadaABBOTT PARK, Ill. | Abbott has announced that the Xience Xpeditio Everolimus Eluting Coronary Stent System has received Health Canada approval and is launching immediately in Canada. Getting prescribing rightThese pharmacy owners have discovered that prescriptive authority is just the first step toward growing a business in primary care pharmacy Update on Omega-3 fatty acids Bottom line? There may be some benefit to taking Omega-3s, combined with other dietary measures. Clinical Notes: New oral anticoagulants increase GI bleeding risk New oral anticoagulants increase the risk of gastrointestinal bleeding, according to a recent systematic review and meta-analysis. Spotlight: Putting patients at EASE Adverse Reactions Statin discontinuation and intolerance; Prenatal valproic acid exposure and autism risk Drug News - September 2013 Clinical Feature: The other side of statins The truth about non–muscle related adverse effects. Treating the person, not just the disease By focusing on one tree, we can fail to notice the forest Press Review - August 30, 2013 First Previous 308 309 310 311 312 Next Last
